Tumor and CD4 T-cell interactions: tumor escape as result of reciprocal inactivation

被引:22
作者
Flynn, S [1 ]
Stockinger, B [1 ]
机构
[1] Natl Inst Med Res, Div Mol Immunol, London NW7 1AA, England
关键词
D O I
10.1182/blood-2002-10-3030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This paper addresses the capacity of naive, effector, and memory CD4 T cells to control growth of a major histocompatibility complex (MHC) class II-positive B-cell lymphoma in vivo. To assess the role of T cells on their own without contributions by B cells, antibodies, or natural killer (NK) cells, we generated pure effector or memory CD4 T cells in Rag(-/-)gc(-/-) mice deficient in endogenous lymphocytes and NK cells. Lymphoma cells expressing a model antigen were injected into mice with T cells of cognate specificity that were either naive or in effector or resting memory state. Naive T cells were unable to prevent tumor growth, probably due to delay of efficient cross-presentation by dendritic cells. However, both effector and memory T cells, dependent on the amount of antigen available, controlled the tumor for a considerable period of time without the need for dendritic cell stimulation. Nevertheless, the tumor eventually grew uncontrolled in all cases. This was not because of a defect in T-cell homing to the tumor site or loss of MHC class II or costimulatory molecules by the tumor, but reflected mutual paralysis of T-cell responsiveness and antigen processing by tumor cells. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:4472 / 4478
页数:7
相关论文
共 72 条
  • [11] IFN-αβ promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines
    Cho, HJ
    Hayashi, T
    Datta, SK
    Takabayashi, K
    Van Uden, JH
    Horner, A
    Corr, M
    Raz, E
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (10) : 4907 - 4913
  • [12] Tumor cell responses to IFNγ affect tumorigenicity and response to IL-12 therapy and antiangiogenesis
    Coughlin, CM
    Salhany, KE
    Gee, MS
    LaTemple, DC
    Kotenko, S
    Ma, XJ
    Gri, G
    Wysocka, M
    Kim, JE
    Liu, L
    Liao, F
    Farber, JM
    Pestka, S
    Trinchieri, G
    Lee, WMF
    [J]. IMMUNITY, 1998, 9 (01) : 25 - 34
  • [13] PROTECTION AGAINST SYNGENEIC LYMPHOMA BY A LONG-LIVED CYTO-TOXIC T-CELL CLONE
    DAILEY, MO
    PILLEMER, E
    WEISSMAN, IL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (17): : 5384 - 5387
  • [14] ENHANCED IN-VIVO GROWTH AND RESISTANCE TO REJECTION OF TUMOR-CELLS EXPRESSING DOMINANT-NEGATIVE IFN-GAMMA RECEPTORS
    DIGHE, AS
    RICHARDS, E
    OLD, LJ
    SCHREIBER, RD
    [J]. IMMUNITY, 1994, 1 (06) : 447 - 456
  • [15] GENE-TRANSFER AS CANCER-THERAPY
    DRANOFF, G
    MULLIGAN, RC
    [J]. ADVANCES IN IMMUNOLOGY, VOL 58, 1995, 58 : 417 - 454
  • [16] VACCINATION WITH IRRADIATED TUMOR-CELLS ENGINEERED TO SECRETE MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR STIMULATES POTENT, SPECIFIC, AND LONG-LASTING ANTITUMOR IMMUNITY
    DRANOFF, G
    JAFFEE, E
    LAZENBY, A
    GOLUMBEK, P
    LEVITSKY, H
    BROSE, K
    JACKSON, V
    HAMADA, H
    PARDOLL, D
    MULLIGAN, RC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) : 3539 - 3543
  • [17] Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity
    Dredge, K
    Marriott, JB
    Todryk, SM
    Muller, GW
    Chen, R
    Stirling, DI
    Dalgleish, AG
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (10) : 4914 - 4919
  • [18] Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells
    Fiebiger, E
    Meraner, P
    Weber, E
    Fang, IF
    Stingl, G
    Ploegh, H
    Maurer, D
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (08) : 881 - 892
  • [19] Antiangiogenic gene therapy
    Folkman, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) : 9064 - 9066
  • [20] FUJIWARA H, 1984, J IMMUNOL, V133, P1671